Gene and Cell Therapy – News and Features

An Oregon Health & Science University-developed platform for cytomegalovirus-based vaccines shows promise as a “shield” against cancer. OHSU researchers used CMV to transport cancer-related antigens that would cause an immune response.

An interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be captured by lipid nanoparticles, which are akin to tiny bubbles of fat.

In this article, we explore how researchers are tackling some of the challenges preventing cell therapies from being more widely used. We also outline advances in manufacturing and regulatory approval processes that will help expand patient access to life-changing treatments.

Finalists for the New Product Award at the SLAS Europe conference showcase cutting-edge innovations in life sciences, evaluated on technical merit, commercial feasibility, originality, impact and market opportunity. Here, we take a look at the six nominees and the products competing for this year’s award.

In this article, we will explore the obstacles that reduce the efficacy of cell-based cancer immunotherapy and strategies to overcome them.

Researchers have developed an approach to “deleting” a blood system affected by leukemia while simultaneously building up a new, healthy system with donor blood stem cells.

Scientists have engineered an adeno-associated virus (AAV) that efficiently crosses the blood-brain barrier in human cell models and delivers genes throughout the brain in humanized mice.

From AI's transformative role in drug discovery and CRISPR breakthroughs to the rise of biosimilars and real-world data. Learn how these innovations are reshaping pharma and driving progress in 2024.

An estimated 40% of low-back pain cases are attributed to degeneration of the cushiony intervertebral discs that absorb shocks and provide flexibility to the spine.

This article explores the challenges and strategies involved in transitioning to automated cryogenic storage systems. From assessing current infrastructure to gaining organizational buy-in and selecting appropriate containers, follow these steps to help ensure a successful transition to automated cryogenic storage.